Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Aldel Financial Inc Cl A
Arcimoto, Inc. - Common Stock
Bank of Nova Scotia
Barings Global Short Duration High Yield Fund Common Shares of Beneficial
Chicken Soup for the Soul Entertainment, Inc. - Class A Common Stock
Eco Innovation Grp Inc
Howard Hughes Corporation (The) Common Stock
InnovAge Holding Corp. - Common Stock
Ironnet Inc
Kailera Therapeutics, Inc. - Common stock
Niu Technologies - American Depositary Shares
Pretium Resources, Inc. Ordinary Shares (Canada)
Select Interior Concepts, Inc. - Class A Common Stock
Sigma Labs, Inc. - Common Stock
Silo Wellness Inc
Silo Wellness Inc
Volcon, Inc. - Common stock
Volta Inc
WiMi Hologram Cloud Inc. - Class B Ordinary Shares
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Kailera Therapeutics, Inc.
Kailera Therapeutics to Present at ObesityWeek 2026
November 10, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Therapeutics to Participate in November Investor Conferences
November 03, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Therapeutics to Participate in September Investor Conferences
September 16, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 12, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
August 11, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535
July 07, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
May 26, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 20, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KLRA
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 16, 2026
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions
October 01, 2024
From
Kailera Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.